Hims & Hers Health, Inc.
Panjang
Telah dikemas kini

Safe Entry Zone HIMS Part-2

297
After the 150%+ profit reached. in part-0

Stock reached blue zone which was part-1 analysis target.

Now Target Reached.

Despite the termination of Novo drugs with HIMs which will hurt HIMS on long run for sure unless they figure out something.

I strongly believe despite negativity and all bad news price subjected to 55%+ run to Red Zone.

STOP LOSS is below Blue Zone. MUST BE.

Price is Volatile at current price level due to Buyers and Sellers Fighting. which is fine.

Note: 1- Potentional of Strong Buying Zone:

We have two scenarios must happen at The Mentioned Zone:

Scenarios One: strong buying volume with reversal Candle.
Scenarios Two: Fake Break-Out of The Buying Zone.

Both indicate buyers stepping in strongly. NEVER Join in unless one showed up.

2- How to Buy Stock:

On 15M TF when Marubozu Candle show up which indicate strong buyers stepping-in.
Buy on 0.5 Fibo Level of the Marubozu Candle, because price will always and always re-test the imbalance.
Nota
all Major Indices at Strong Resistances its only reason to wait for Strong buyers stepping in at current price level.
Dagangan aktif
bearish volume building up at buying zone means be out of the market
Dagangan ditutup: sasaran tercapai
first candle is Morubozu if you follow "2- How to Buy Stock:

On 15M TF when Marubozu Candle show up which indicate strong buyers stepping-in.
Buy on 0.5 Fibo Level of the Marubozu Candle, because price will always and always re-test the imbalance."

you would get the very bottom and secure 9% profit yet and more.

I Also cant follow anymore with the trade im getting busying on my own trades Wish you best luck, sorry cheers

Next Station 65$ price level
Nota
price may retest 43.20-42.60$ as Interest Zone.
Nota
45.70$ price level is where new traders should take profit and wait pullback, professional trades I believe can manage his risk.
Nota
price rejected from 45.70$ going to retest 43.20-42.60$ as Interest Zone.

and omg i cant stop typing BYE!

Penafian

Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.